By Editor • September 3, 2026 • 1 min read
Abivax, a promising French biotech firm, remains unacquired despite expectations of a $20 billion deal, leaving investors concerned.
Read moreBy Editor • September 2, 2026 • 1 min read
Nike's upcoming earnings call will focus on new CFO David Denton's strategies as investors contend with ongoing company challenges.
Read moreBy Editor • September 1, 2026 • 1 min read
Shenzhen is seeing a wave of global investors drawn to its AI and robotics sectors, with major conferences led by HSBC, UBS, and Nomura highlighting emerging opportunities.
Read moreBy Editor • August 31, 2026 • 2 min read
Ryan Breslow is raising up to $27 million in bridge funding to stabilize Bolt, a company that has seen its valuation plummet dramatically.
Read moreBy Editor • August 24, 2026 • 1 min read
Exhibit tables for TechCrunch Disrupt 2026 are available, offering startups a prime opportunity to engage with industry leaders.
Read moreBy Editor • August 23, 2026 • 1 min read
A 30% drop in South Korea's stock market since June has left investors devastated, raising political concerns for President Lee Jae Myung's government.
Read moreBy Editor • August 20, 2026 • 2 min read
TechCrunch Disrupt 2026 offers investors a unique chance to discover emerging AI companies and network with industry leaders in San Francisco this October.
Read moreBy Editor • August 17, 2026 • 1 min read
Anthropic's annualized revenue has surged to $65 billion, outpacing OpenAI's growth as both prepare for impending IPOs.
Read more
